DocWire News Editors

DocwireNews

<p>Tranexamic acid (TXA) is one of the most common hemostatic drugs used in surgical patients and is known to help reduce blood loss volume. Here, researchers reviewed the literature comparing intravenous (IV) and topical TXA administration, as well as combined delivery. A total of 26 randomized, controlled trials were included in the analysis. Topical and IV patients did not have significant differences in total blood loss volume, drain blood loss, postoperative hemoglobin (Hb) levels, Hb decline, length of hospital stay, transfusion rate, and occurrence of venous thromboembolism (VTE). However, single-route patients had significantly increased total blood loss volume, greater Hb decline, and higher transfusion rates, but drain blood loss, postoperative Hb levels, and VTE events did not largely differ between the groups.<p>Read more: <a href="https://bmjopen.bmj.com/content/9/1/e024350?rss=1">https://bmjopen.bmj.com/content/9/1/e024350?rss=1</a></p></p>


Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Meta-analysis: Intravenous, Topical or Combined Routes of Tranexamic Acid Administration in Patients Undergoing Total knee and Hip Arthroplasty

Orthopedics

Tranexamic acid (TXA) is one of the most common hemostatic drugs used in surgical patients and is known to help reduce blood loss volume. Here, researchers reviewed the ...

Meta-analysis: Intravenous, Topical or Combined Routes of Tranexamic Acid Administration in Patients

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe